Wells Fargo lowered the firm’s price target on Teladoc to $17 from $18 and keeps an Equal Weight rating on the shares. While Teladoc continues to make progress on margins, the company’s latest long-term revenue growth outlook drives further estimate revisions and makes it difficult to justify a premium multiple, the firm argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TDOC: